

In the blister 10 capsules. In packing 5 blisters.
Chondroitin is a stimulator of cartilage tissue regeneration (chondroprotector), a high molecular weight mucopolysaccharide derived from the cartilage of cattle trachea. Affects metabolic processes in hyaline and fibrous cartilage, reduces degenerative changes in the cartilage tissue of the joints, stimulates the biosynthesis of glycosaminoglycans. Suppresses the activity of enzymes that cause damage to cartilage tissue, promotes the regeneration of the articular sacs and the cartilaginous surfaces of the joints, increases the production of intraarticular fluid. It slows down bone resorption and reduces Calcium loss, accelerates bone repair processes. With drug treatment, pain decreases and mobility of the affected joints improves. The therapeutic effect persists for a long time after the end of the course of treatment.
Degenerative diseases of the joints and spine:
- Osteoarthrosis.
- Osteocondritis of the spine.
- Pregnancy.
- Lactation (breastfeeding).
- Hypersensitivity to the drug.
The drug is contraindicated for use during pregnancy and lactation (breastfeeding).
The drug is prescribed inside. The therapeutic effect develops within 8-12 weeks of taking the drug.
Adults - 750 mg 2 times / day for the first 3 weeks, then 500 mg 2 times / day for 9 weeks.
Children older than 5 years, the drug is prescribed in a dose of 500-750 mg / day.
Gastrointestinal: rarely - nausea, vomiting.
Other: rarely - allergic reactions.
Caution should be given to patients with bleeding, as well as patients with a tendency to bleeding.
With simultaneous use of the drug Chondroitin with other drugs may increase the effects of indirect anticoagulants, antiplatelet agents, fibrinolytics.
The drug should be stored in a dry, dark place at a temperature not exceeding 20 ° C.
3 years.